Synopsys, Inc. $SNPS Shares Sold by OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC

OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC lessened its holdings in Synopsys, Inc. (NASDAQ:SNPSFree Report) by 57.4% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 8,000 shares of the semiconductor company’s stock after selling 10,801 shares during the period. OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC’s holdings in Synopsys were worth $3,758,000 as of its most recent filing with the Securities & Exchange Commission.

Several other large investors have also modified their holdings of SNPS. Thurston Springer Miller Herd & Titak Inc. acquired a new position in shares of Synopsys in the 4th quarter valued at $28,000. Caitong International Asset Management Co. Ltd acquired a new position in shares of Synopsys in the 4th quarter valued at $28,000. Atlas Capital Advisors Inc. acquired a new position in shares of Synopsys in the 4th quarter valued at $32,000. Oakworth Capital Inc. lifted its stake in shares of Synopsys by 3,700.0% in the 4th quarter. Oakworth Capital Inc. now owns 76 shares of the semiconductor company’s stock valued at $36,000 after purchasing an additional 74 shares during the last quarter. Finally, Greenline Wealth Management LLC acquired a new position in shares of Synopsys in the 4th quarter valued at $37,000. Institutional investors and hedge funds own 85.47% of the company’s stock.

Synopsys Price Performance

SNPS opened at $454.38 on Tuesday. The stock’s 50-day moving average price is $474.73 and its 200 day moving average price is $461.19. The company has a current ratio of 1.43, a quick ratio of 1.32 and a debt-to-equity ratio of 0.33. Synopsys, Inc. has a 12-month low of $376.18 and a 12-month high of $651.73. The firm has a market cap of $87.00 billion, a price-to-earnings ratio of 105.18, a PEG ratio of 2.67 and a beta of 1.22.

Synopsys (NASDAQ:SNPSGet Free Report) last announced its quarterly earnings data on Wednesday, May 27th. The semiconductor company reported $3.35 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.15 by $0.20. Synopsys had a return on equity of 5.83% and a net margin of 8.91%.The business had revenue of $2.28 billion during the quarter, compared to analysts’ expectations of $2.25 billion. During the same quarter last year, the business posted $3.67 EPS. The business’s quarterly revenue was up 41.9% compared to the same quarter last year. Synopsys has set its FY 2026 guidance at 14.720-14.800 EPS and its Q3 2026 guidance at 3.630-3.690 EPS. As a group, sell-side analysts expect that Synopsys, Inc. will post 10.65 earnings per share for the current year.

Analysts Set New Price Targets

Several equities analysts recently issued reports on SNPS shares. Citigroup increased their target price on Synopsys from $600.00 to $610.00 and gave the stock a “buy” rating in a research note on Thursday, May 28th. Morgan Stanley increased their target price on Synopsys from $480.00 to $525.00 and gave the stock an “equal weight” rating in a research note on Thursday, May 28th. BNP Paribas Exane increased their target price on Synopsys from $425.00 to $450.00 and gave the stock an “underperform” rating in a research note on Thursday, May 28th. Stifel Nicolaus increased their target price on Synopsys from $550.00 to $600.00 and gave the stock a “buy” rating in a research note on Thursday, May 28th. Finally, The Goldman Sachs Group set a $600.00 target price on Synopsys and gave the stock a “buy” rating in a research note on Wednesday, February 25th. Nine research analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Hold” and an average price target of $563.81.

Check Out Our Latest Stock Analysis on Synopsys

Insider Transactions at Synopsys

In other Synopsys news, CFO Shelagh Glaser sold 3,394 shares of the business’s stock in a transaction that occurred on Friday, June 12th. The shares were sold at an average price of $450.02, for a total transaction of $1,527,367.88. Following the completion of the transaction, the chief financial officer owned 14,358 shares in the company, valued at $6,461,387.16. The trade was a 19.12% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.56% of the stock is owned by corporate insiders.

Synopsys Company Profile

(Free Report)

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.

See Also

Institutional Ownership by Quarter for Synopsys (NASDAQ:SNPS)

Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.